Diabetic Ketoacidosis Author: Heather Lochnan, MD
Approved for review - 2009-03-25
Author information and module status
Prevention
Screening
Diagnosis
Consultation for Diagnosis
Hospitalization
Non-drug Therapy
Drug Therapy
Patient Education
Consultation for Management
Follow-up

Tables
Figures
References
Glossary
What's New
Patient Information
Additional Resources
Tools
Additional Resources

Clinical Information
Guideline
   Diabetes Care
 Hyperglycemic crises in patients with diabetes mellitus
   Pediatrics
 European Society for Paediatric Endocrinology/Lawson Wilkins Pediatric Endocrine Society consensus statement on diabetic ketoacidosis in children and adolescents
Article
   American Journal of Medicine
 Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis
   Archives of Internal Medicine
 Diabetic ketoacidosis in type 1 and type 2 diabetes mellitus: clinical and biochemical differences
   British Medical Journal
 Disorders of sodium balance
   Diabetes Care
 Treatment of diabetic ketoacidosis with subcutaneous insulin aspart
   New England Journal of Medicine
 Clinical practice. Management of hyperglycemia in the hospital setting
Review
   Annals of Internal Medicine
 Narrative review: ketosis-prone type 2 diabetes mellitus
Commentary
   ACP Journal Club
      Diabetes mellitus, hypoglycemia, hyperglycemia, diabetic ketoacidosis
 - Review: Rosiglitazone or pioglitazone as add-on therapy is effective for glycemic control in type 2 diabetes
 2002 - Review: Metformin does not increase fatal or nonfatal lactic acidosis or blood lactate levels in type 2 diabetes mellitus
 2001 - Review: Stress hyperglycemia after ischemic stroke indicates a greater risk for death in patients without diabetes

Educational Resources
Educational Syllabus
   MKSAP 12
 Diabetic Ketoacidosis

Patient Information
Web
 American Diabetes Association: Ketoacidosis
FAQs | Patient Information
Ebenezer A. Nyenwe, MD, editorial consultant, has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. Heather Lochnan, MD has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations.
Deborah Korenstein, MD, FACP, Co-Editor, PIER, has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. Richard B. Lynn, MD, FACP, Co-Editor, PIER, has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations.


The information included herein should never be used as a substitute for clinical judgment and does not represent an official position of ACP. Because all PIER modules are updated regularly, printed web pages or PDFs may rapidly become obsolete. Therefore, PIER users should compare the date of the last update on the website with any printout to ensure that the information being referred to is the most current available.
PIER is copyrighted © 2012 by the American College of Physicians,
190 N. Independence Mall West, Philadelphia, PA 19106-1572, USA.